MYCIO Wealth Partners’s Teva Pharmaceuticals TEVA Stock Holding History

MYCIO Wealth Partners’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,130	Closed	-$52K	–	602
2016 Q3	$52K	Buy	1,130 +75	+7%	+$3.91K	0.01%	333
2016 Q2	$53K	Buy	1,055 +35	+3%	+$1.86K	0.01%	336
2016 Q1	$55K	Sell	1,020 -129	-11%	-$7.57K	0.01%	310
2015 Q4	$75K	Buy	1,149 +98	+9%	+$6.06K	0.01%	246
2015 Q3	$59K	Buy	1,051 +31	+3%	+$2.01K	0.01%	273
2015 Q2	$60K	Hold	1,020	–	–	0.01%	273
2015 Q1	$64K	Buy	1,020 +20	+2%	+$1.16K	0.01%	258
2014 Q4	$58K	Sell	1,000 -359	-26%	-$20K	0.01%	250
2014 Q3	$73K	Sell	1,359 -500	-27%	-$26.5K	0.02%	217
2014 Q2	$97K	Hold	1,859	–	–	0.02%	197
2014 Q1	$98K	Buy	1,859 +500	+37%	+$23.1K	0.02%	188
2013 Q4	$54K	Hold	1,359	–	–	0.01%	240
2013 Q3	$51K	Hold	1,359	–	–	0.01%	230
2013 Q2	$53K	Buy	+1,359	New	+$52.9K	0.01%	227

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

MYCIO Wealth Partners's TEVA Position: Q4 2016 in Review

MYCIO Wealth Partners sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 1,130 shares — an estimated $52K sold.

MYCIO Wealth Partners first reported a position in TEVA in Q2 2013 and held it in 14 quarters. The position peaked at $98K in Q1 2014. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

MYCIO Wealth Partners reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
MYCIO Wealth Partners sold 1,130 Teva Pharmaceuticals shares in Q4 2016, an estimated $52K.
MYCIO Wealth Partners first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 14 quarters.
MYCIO Wealth Partners's Teva Pharmaceuticals position peaked at $98K in Q1 2014.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on MYCIO Wealth Partners's 13F filing for Q4 2016, filed 1 Feb 2017.